FBInvestor
Stocks / Aslan Pharmaceuticals Lt Adr
Institutional Ownership

Aslan Pharmaceuticals Lt Adr

CUSIP 04522R309COMASLNEURQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon